Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-40 |
filingDate |
2003-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2011-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2011-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-101058696-B1 |
titleOfInvention |
Compounds and Methods for the Treatment or Prevention of Furabivirus Infections |
abstract |
The present invention provides novel compounds and their pharmaceutically acceptable salts represented by the following structural formula (I) for the treatment of Furavivirida virus infection. |
priorityDate |
2002-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |